Erasca, Inc. (ERAS) intrinsic value & 10-year financials
Erasca, Inc. (ERAS) has no Graham intrinsic value right now because the formula needs positive earnings.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $13.39
- Market cap
- $3.8B
- Revenue (FY2025)
- —
- ROIC (10-yr avg)
- 22.8%
- Free cash flow (FY2025)
- -$95.6M
ERAS 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | — | -$124.5M | -$0.44 | -$95.6M | — | -40.5% |
| FY2024 | — | -$161.7M | -$0.69 | -$109.5M | — | -52.9% |
| FY2023 | — | -$125.0M | -$0.83 | -$103.0M | — | -54.7% |
| FY2022 | — | -$242.8M | -$1.99 | -$117.8M | — | -164.1% |
| FY2021 | — | -$122.8M | -$1.85 | -$90.8M | — | 391.6% |
| FY2020 | — | -$101.7M | — | -$33.6M | — | 57.4% |
| FY2019 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Erasca, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Erasca, Inc. has historically struggled to out-earn its cost of capital, averaging just -14.7% ROIC.
Erasca, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Erasca, Inc. is evaluated under Benjamin Graham's defensive framework using SEC EDGAR fundamentals using an 8.5 + 2g earnings multiple and a 5.1% AAA bond-yield baseline.